Cefaval TZ 1.125 Injection
Marketer
Wonne International
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Cefaval TZ 1.125 Injection
Ceftriaxone and Sulbactam injection (Cefaval TZ 1.125 equivalent) is a dual-action antibiotic. It's indicated for a range of bacterial infections, inhibiting microbial growth and halting infection progression. Administration must be solely under medical guidance. Consistent adherence to the prescribed dosage schedule is crucial; complete the full course, even with symptom improvement, as premature cessation can reduce efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening side effects require immediate medical attention. Seek immediate medical help for allergic reactions (e.g., rash, itching, swelling, dyspnea). Disclose all current medications to your physician before starting treatment, particularly if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid driving if drowsiness or dizziness occur. Ensure adequate rest, a nutritious diet, and sufficient hydration for optimal recovery. Your physician may order blood tests and other diagnostics to monitor treatment response.
Primary Ingredients of Cefaval TZ 1.125 Injection
No text was provided to rewrite.
Uses of Cefaval TZ 1.125 Injection
Infections caused by bacteria
Major Benefits of Cefaval TZ 1.125 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cefaval TZ 1.125 Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Cefaval TZ 1.125 Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
How Cefaval TZ 1.125 Injection works:
Ceftriaxone and Tazobactum, combined as Cefaval TZ 1.125 Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Tazobactum, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concomitant alcohol and Cefaval TZ 1.125 Injection use.
PregnancySAFE IF PRESCRIBED
The injectable medication Cefaval TZ 1.125 is typically deemed safe for use during pregnancy. Preclinical trials in animals have revealed minimal or no negative consequences for fetal development; nevertheless, data from human clinical trials are scarce.
Breast feedingCAUTION
The administration of Cefaval TZ 1.125 Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout their treatment course and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Cefaval TZ 1.125 Injection can induce drowsiness, visual disturbances, and dizziness. Driving should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cefaval TZ 1.125 Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
Exercise caution when administering Cefaval TZ 1.125 Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Cefaval TZ 1.125 Injection is generally unnecessary in patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Cefaval TZ 1.125 Injection :
Omitting a scheduled dose of Cefaval TZ 1.125 Injection necessitates contacting your physician.
Facts to Know About Cefaval TZ 1.125 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently